Vir Biotechnology, Inc. Research And Development Expense

• Vir Biotechnology, Inc. showed a decrease of -10.0% in Research And Development Expense from 2024 to 2025.
• This data is from Vir Biotechnology, Inc.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), Vir Biotechnology, Inc.'s Research And Development Expense has grown by 629.4%.
• Historical annual values: Fiscal year 2025: $455.97 million | Fiscal year 2024: $506.50 million | Fiscal year 2023: $579.72 million | Fiscal year 2022: $474.65 million | Fiscal year 2021: $448.01 million | Fiscal year 2020: $302.41 million | Fiscal year 2019: $148.47 million | Fiscal year 2018: $100.23 million | Fiscal year 2017: $62.51 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026